A non-synonymous variant rs12614 of complement factor B associated with risk of chronic hepatitis B in a Korean

Jung Yeon Seo1,2, Joong-Gon Shin1,3, Byeong Ju Youn2

  • 1Current address: Department of Core Technology, R&D Center, LG Household & Healthcare (LG H&H), Seoul, 07795, South Korea.

BMC Medical Genetics
|December 18, 2020
PubMed

Insights

The complement factor B (CFB) rs12614 variant significantly impacts chronic hepatitis B (CHB) risk in Koreans. This finding validates rs12614 as a potential causal genetic marker for CHB susceptibility.

Area of Science:

  • Genetics
  • Hepatology
  • Immunology

Background:

  • Hepatitis B virus (HBV) infection causes chronic hepatitis B (CHB) and hepatocellular carcinoma.
  • Previous genome-wide association studies (GWAS) identified the complement factor B (CFB) rs12614 single nucleotide polymorphism (SNP) as associated with CHB risk.

Purpose of the Study:

  • To fine-map the CFB rs12614 SNP to validate its genetic effect on CHB susceptibility in a Korean population.
  • To identify potential additional causal variants around rs12614 associated with CHB.

Main Methods:

  • Genotyping of 10 CFB genetic polymorphisms in 1716 individuals (955 CHB patients, 761 controls).
  • Fine-mapping, linkage disequilibrium, and conditional analyses were performed.

Main Results:

  • The non-synonymous variant rs12614 (Arg32Trp) showed a significant association with CHB risk (OR=0.43, P=5.91×10⁻¹⁰).
  • rs12614 demonstrated an independent genetic effect on CHB susceptibility.
  • Higher genetic risk scores (GRSs) were observed in CHB patients compared to controls, with increased odds ratios correlating with cumulative GRS.

Conclusions:

  • The rs12614 variant has a significant genetic effect on CHB risk in the Korean population.
  • rs12614 is a potential causal genetic variant for CHB susceptibility.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.9K
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.4K
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
18.4K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
84